health

There seems to be an inclination among policy-makers that adherence to evidence-based policy-making is a luxury we can only afford when not in a crisis.

As of now, every bit of COVID-19 good news is being buried or tainted with doubts.

Clinical trials do more than inform us whether a drug is effective. They inform us when a drug is effective, in what combinations, in what dosages, and what are the counter indications.

Due to coronavirus, governments across the globe are considering and/or are doing something they certainly could not do before: implement mass surveillance programs to track COVID-19 patients.

I hope you are doing well–for access to medical help is increasingly threatened.

If the COVID-19 crisis has taught us one thing—aside from the need to wash your hands often—it is that the FDA’s approval process for much-needed medicine to those with debilitating and terminal diseases is in dire need of reform.

The United States has taken unprecedented actions to halt the spread of the novel coronavirus and the illness it causes, COVID-19. How bad will this be for the economy?

Junk science and scare stories stampede countries into taking drastic, unnecessary action.

Here’s what Trump should say during his next coronavirus press conference.

Our lives and economy have been disrupted on an unprecedented scale by COVID-19. How do we calculate the societal impact?

Our system may not be the fastest, but it’s giving us trustworthy answers.

Social distancing is the prescribed solution to the COVID-19 pandemic. Did we ever consider the other options?

A professor and group of student researchers at the University of Wisconsin at Eau Claire claim they found elevated particulate levels associated with frac-sand mining.